LYMPHOMA USO 16065

A Phase 2b Randomized Study to Assess the Efficacy and Safety of the Combination of Ublituximab + TGR-1202 and TGR-1202 alone in Patients with Previously Treated Diffuse Large B-Cell Lymphoma (UTX-TGR-205)

Disease Types

Lymphoma

Available at

BethesdaClintonColumbiaRockvilleSilver SpringWheaton

Contact

Cheryl Young
(410) 964-2212 ext 1137